Home › Companies › AGILON HEALTH INC. › 2024-2025

AGILON HEALTH INC. 2024-2025 Proxy Voting Records

Compiled from SEC Form N-PX filings and AGILON HEALTH INC.’s Form 8-K, filed May 30, 2025 (Item 5.07 on EDGAR). Page generated October 14, 2026.

4Ballot items
174Asset managers
901Fund votes
May 28, 2025Meeting date

Results at a glance

Meeting of May 28, 2025: 4 items on AGILON HEALTH INC.’s Form 8-K, filed May 30, 2025: 2 elected · 2 approved.

Material dissent

None.

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore AGILON HEALTH INC. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by AGILON HEALTH INC.

These tallies are AGILON HEALTH INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 30, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

AGILON HEALTH INC. — official shareholder meeting results, meeting held May 28, 2025
Ballot item	For	Against	Abstain	Withheld	Broker non-votes	Support (of votes cast)	Reported outcome	Voting standard
Elect Director: Silvana Battaglia	367,732,187	2,575,657	73,996	--	19,577,901	99.3%	Elected	—
Elect Director: Sharad Mansukani, M.D.	316,017,915	54,325,054	38,871	--	19,577,901	85%	Elected	—
2. Ratification of Independent Registered Public Accounting Firm	385,547,549	4,346,548	65,644	--	--	99%	Approved	—
3. Non-Binding Vote on Executive Compensation	286,771,841	83,515,983	94,016	--	19,577,901	77%	Approved	—

Source: AGILON HEALTH INC., Form 8-K, filed with the SEC on May 30, 2025 — read the filing on EDGAR.

How asset managers voted at the AGILON HEALTH INC. 2024-2025 meeting

Each item below shows how the 174 asset managers that disclosed a AGILON HEALTH INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.

1. Elect Director: Sharad Mansukani, M.D.

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 3 wordings of this item as funds reported it.

85% Majority: yes · of votes cast

FOR 85%AGAINST

FOR: 316,017,915AGAINST: 54,325,054

Details: description as filed, official tally, votes by 52 asset managers

Description as filed by funds: Election of Class I Directors: Sharad Mansukani, M.D.

AGILON HEALTH INC.’s own tally for this item (“Elect Director: Sharad Mansukani, M.D.”): 316,017,915 for, 54,325,054 against, per its Form 8-K filed May 30, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal No. 1 - Election of Directors The following two individuals were elected to the Company's Board of Directors to serve as Class I directors until the Company's 2028 annual meeting of stockholders and until their successors have been duly elected and qualified.”
Support: 85% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 52 asset managers below reported 172,168,946 for, 22,625,125 against, 31,549 abstained.

FOR

FOR: 172,168,946AGAINST: 22,625,125ABSTAIN: 31,549

Largest asset managers voting on “Election of Class I Directors: Sharad Mansukani, M.D.” at AGILON HEALTH INC., 2024-2025
Asset manager	For	Against	Abstain	Vote
Capital Group	65,184,327	0	0	For
Vanguard	35,662,457	62,800	0	For
Fidelity	27,540,308	219,883	0	For
Morgan Stanley	20,314,070	0	0	For
BlackRock	0	11,091,520	0	Against
Brighthouse	7,214,827	132,301	31,549	For
NEW ECONOMY FUND	5,866,895	0	0	For
TIAA	0	5,791,820	0	Against
Charles Schwab	4,929,028	0	0	For
Equitable	3,177,976	818,886	0	Mixed
Hartford	800,962	0	0	For
Invesco	0	715,488	0	Against
Exchange Place Advisors Trust	0	672,080	0	Against
QUANTITATIVE MASTER SERIES LLC	0	518,720	0	Against
Global X	0	409,144	0	Against
Goldman Sachs	0	399,439	0	Against
State Street	381,535	1,048	0	For
Lincoln Financial	285,005	16,528	0	Mixed
DWS	0	245,556	0	Against
TIFF INVESTMENT PROGRAM	0	228,279	0	Against
NORTHERN LIGHTS FUND TRUST III	184,911	0	0	For
Northern Trust	0	157,172	0	Against
AIG/SunAmerica	0	151,134	0	Against
American Century	0	144,998	0	Against
T. Rowe Price	137,910	0	0	For

Showing the 25 largest of 52 asset managers. See all 52 in the interactive database.

2. Elect Director: Silvana Battaglia

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 2 wordings of this item as funds reported it.

99.3% Majority: yes · of votes cast

FOR 99.3%

FOR: 367,732,187AGAINST: 2,575,657

Details: description as filed, official tally, votes by 47 asset managers

Description as filed by funds: Election of Class I Directors: Silvana Battaglia

AGILON HEALTH INC.’s own tally for this item (“Elect Director: Silvana Battaglia”): 367,732,187 for, 2,575,657 against, per its Form 8-K filed May 30, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal No. 1 - Election of Directors The following two individuals were elected to the Company's Board of Directors to serve as Class I directors until the Company's 2028 annual meeting of stockholders and until their successors have been duly elected and qualified.”
Support: 99.3% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 47 asset managers below reported 180,502,548 for, 303,747 against.

FOR

FOR: 180,502,548AGAINST: 303,747

Largest asset managers voting on “Election of Class I Directors: Silvana Battaglia” at AGILON HEALTH INC., 2024-2025
Asset manager	For	Against	Vote
Capital Group	65,184,327	0	For
Vanguard	29,718,275	0	For
Fidelity	26,889,225	0	For
Morgan Stanley	20,314,070	0	For
BlackRock	11,091,520	0	For
Brighthouse	6,495,079	0	For
NEW ECONOMY FUND	5,866,895	0	For
TIAA	5,791,820	0	For
Equitable	3,996,862	0	For
Invesco	715,488	0	For
Exchange Place Advisors Trust	672,080	0	For
QUANTITATIVE MASTER SERIES LLC	518,720	0	For
Goldman Sachs	399,439	0	For
State Street	382,583	0	For
Lincoln Financial	285,005	16,528	Mixed
DWS	245,556	0	For
TIFF INVESTMENT PROGRAM	228,279	0	For
NORTHERN LIGHTS FUND TRUST III	0	184,911	Against
Northern Trust	157,172	0	For
AIG/SunAmerica	151,134	0	For
American Century	144,998	0	For
T. Rowe Price	137,910	0	For
Voya	133,598	0	For
John Hancock	111,897	0	For
JPMorgan	109,594	0	For

Showing the 25 largest of 47 asset managers. See all 47 in the interactive database.

3. 3. Non-Binding Vote on Executive Compensation

Official result Fund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Approved

Combines 8 wordings of this item as funds reported it.

77% Approved · of votes cast

FOR 77%AGAINST

FOR: 286,771,841AGAINST: 83,515,983

Details: description as filed, official tally, votes by 174 asset managers

Description as filed by funds: TO APPROVE, BY ADVISORY VOTE, THE COMPENSATION PAID TO THE COMPANY'S NAMED EXECUTIVE OFFICERS.

AGILON HEALTH INC.’s own tally for this item (“3. Non-Binding Vote on Executive Compensation”): 286,771,841 for, 83,515,983 against — passed, per its Form 8-K filed May 30, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal No. 3 - Non-Binding Vote on Executive Compensation The stockholders approved, on an advisory, non-binding basis, the compensation paid to the Company's named executive officers.”
Support: 77% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 53 asset managers voting on “TO APPROVE, BY ADVISORY VOTE, THE COMPENSATION PAID TO THE COMPANY'S NAMED EXECUTIVE OFFICERS.” at AGILON HEALTH INC., 2024-2025
Asset manager	For	Against	Abstain	Vote
Capital Group	0	65,184,327	0	Against
Vanguard	35,725,257	0	0	For
Fidelity	27,760,191	0	0	For
Morgan Stanley	20,314,070	0	0	For
BlackRock	11,091,520	0	0	For
Brighthouse	7,347,128	0	31,549	For
NEW ECONOMY FUND	0	5,866,895	0	Against
TIAA	5,791,820	0	0	For
Charles Schwab	4,929,028	0	0	For
Equitable	3,996,862	0	0	For
Hartford	800,962	0	0	For
Invesco	0	715,488	0	Against
Exchange Place Advisors Trust	9,549	662,531	0	Against
QUANTITATIVE MASTER SERIES LLC	518,720	0	0	For
Global X	0	409,144	0	Against
Goldman Sachs	399,439	0	0	For
State Street	382,583	0	0	For
Lincoln Financial	285,005	16,528	0	Mixed
DWS	245,556	0	0	For
TIFF INVESTMENT PROGRAM	0	228,279	0	Against
NORTHERN LIGHTS FUND TRUST III	0	184,911	0	Against
Northern Trust	157,172	0	0	For
AIG/SunAmerica	151,134	0	0	For
American Century	0	144,998	0	Against
T. Rowe Price	137,910	0	0	For

Fund voting reports, all 53 managers: 121,367,197 for, 73,537,394 against, 31,549 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 139 asset managers voting on “TO APPROVE, BY ADVISORY VOTE, THE COMPENSATION PAID TO THE COMPANY'S NAMED EXECUTIVE OFFICERS.” at AGILON HEALTH INC., 2024-2025
Asset manager	For	Against	Abstain	Vote
Clayton, Dubilier & Rice, LLC	100,000,000	0	0	For
Capital Group	52	75,334,408	0	Against
Morgan Stanley	47,647,780	0	0	For
Fidelity	20,580,324	0	0	For
Wellington	13,509,685	0	0	For
BlackRock	10,442,103	2,942	0	For
GEODE CAPITAL MANAGEMENT, LLC	6,987,748	0	0	For
Rock Springs Capital Management LP	6,950,000	0	0	For
State Street	6,300,378	0	0	For
Rubicon Founders LLC	0	0	6,292,396	Abstain
Nuveen	5,829,174	0	0	For
Charles Schwab	4,929,040	0	0	For
Northern Trust	2,430,775	0	0	For
Amundi	0	1,484,709	0	Against
MELLON INVESTMENTS Corp	976,727	0	0	For
JPMorgan	949,930	0	0	For
Invesco	0	900,733	0	Against
Vanguard	885,754	0	0	For
DE Shaw	846,689	0	0	For
ALGERT GLOBAL LLC	0	798,011	0	Against
T. Rowe Price	596,000	0	0	For
Citadel	531,950	0	0	For
KENNEDY CAPITAL MANAGEMENT LLC	443,629	0	0	For
UBS	438,932	0	0	For
AllianceBernstein	436,463	0	0	For

Institutional-manager reports, all 139 managers: 234,201,844 for, 80,492,890 against, 6,292,396 abstained. Showing the 25 largest; see all in the interactive database.

4. 2. Ratification of Independent Registered Public Accounting Firm

Official resultAUDIT-RELATEDReported outcome: Approved

Combines 2 wordings of this item as funds reported it.

99% Approved · of votes cast

FOR 99%

FOR: 385,547,549AGAINST: 4,346,548

Details: description as filed, official tally, votes by 53 asset managers

Description as filed by funds: RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE YEAR ENDING DECEMBER 31, 2025.

AGILON HEALTH INC.’s own tally for this item (“2. Ratification of Independent Registered Public Accounting Firm”): 385,547,549 for, 4,346,548 against — passed, per its Form 8-K filed May 30, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal No. 2 - Ratification of Independent Registered Public Accounting Firm The stockholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 53 asset managers below reported 194,904,591 for, 31,549 abstained.

FOR

FOR: 194,904,591ABSTAIN: 31,549

Largest asset managers voting on “RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING” at AGILON HEALTH INC., 2024-2025
Asset manager	For	Abstain	Vote
Capital Group	65,184,327	0	For
Vanguard	35,725,257	0	For
Fidelity	27,760,191	0	For
Morgan Stanley	20,314,070	0	For
BlackRock	11,091,520	0	For
Brighthouse	7,347,128	31,549	For
NEW ECONOMY FUND	5,866,895	0	For
TIAA	5,791,820	0	For
Charles Schwab	4,929,028	0	For
Equitable	3,996,862	0	For
Hartford	800,962	0	For
Invesco	715,488	0	For
Exchange Place Advisors Trust	672,080	0	For
QUANTITATIVE MASTER SERIES LLC	518,720	0	For
Global X	409,144	0	For
Goldman Sachs	399,439	0	For
State Street	382,583	0	For
Lincoln Financial	301,533	0	For
DWS	245,556	0	For
TIFF INVESTMENT PROGRAM	228,279	0	For
NORTHERN LIGHTS FUND TRUST III	184,911	0	For
Northern Trust	157,172	0	For
AIG/SunAmerica	151,134	0	For
American Century	144,998	0	For
T. Rowe Price	137,910	0	For

Showing the 25 largest of 53 asset managers. See all 53 in the interactive database.

Largest AGILON HEALTH INC. shareholders voting in 2024-2025

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 413,023,000 shares outstanding at the time of that meeting.

Fund voting reports: top AGILON HEALTH INC. shareholders by shares voted on “TO APPROVE, BY ADVISORY VOTE, THE COMPENSATION PAID TO THE COMPANY'S NAMED EXECUTIVE OFFICERS.”, 2024-2025
#	Asset manager	% of shares outstanding
1	Capital Group	15.78%
2	Vanguard	8.65%
3	Fidelity	6.72%
4	Morgan Stanley	4.92%
5	BlackRock	2.69%
6	Brighthouse	1.79%
7	NEW ECONOMY FUND	1.42%
8	TIAA	1.40%
9	Charles Schwab	1.19%
10	Equitable	0.97%

Institutional-manager reports: top AGILON HEALTH INC. shareholders by shares voted on “TO APPROVE, BY ADVISORY VOTE, THE COMPENSATION PAID TO THE COMPANY'S NAMED EXECUTIVE OFFICERS.”, 2024-2025
#	Asset manager	% of shares outstanding
1	Clayton, Dubilier & Rice, LLC	24.21%
2	Capital Group	18.24%
3	Morgan Stanley	11.54%
4	Fidelity	4.98%
5	Wellington	3.27%
6	BlackRock	2.53%
7	GEODE CAPITAL MANAGEMENT, LLC	1.69%
8	Rock Springs Capital Management LP	1.68%
9	State Street	1.53%
10	Rubicon Founders LLC	1.52%

Reported AGILON HEALTH INC. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.

AGILON HEALTH INC. holdings and ownership disclosed for the 2024-2025 proxy season
Holder	% outstanding	Disclosure
Morgan Stanley	12.60%	13F
North Peak Capital Management, LLC	9.54%	13G
Vanguard Group	7.33%	13F
BlackRock	5.99%	13F
FMR (Fidelity)	4.62%	13F
Wellington Management	3.63%	13F
Capital World Investors	2.63%	13G
Capital International Investors	2.40%	13G
Citadel Advisors	2.03%	13F
State Street	1.79%	13F

Percentages above are of 413,023,000 shares outstanding, as reported by AGILON HEALTH INC. on its Form 10-Q dated March 31, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from AGILON HEALTH INC.’s 10-Q dated March 31, 2025. This page is a static snapshot rebuilt weekly on October 14, 2026; a live search always shows the current data.

At AGILON HEALTH INC.'s shareholder meeting held May 28, 2025, in the 2024-2025 proxy season, 174 asset managers reported how they voted on 4 ballot items in their SEC Form N-PX filings, covering 901 separate fund positions. On the most widely held item on that ballot — TO APPROVE, BY ADVISORY VOTE, THE COMPENSATION PAID TO THE COMPANY'S NAMED EXECUTIVE OFFICERS. — AGILON HEALTH INC.'s filing reports the proposal as approved, with 77% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: AGILON HEALTH INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 30, 2025.

AGILON HEALTH INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.

Download data (CSV): ballot items · votes by manager · column guide.